跳至主要内容
临床试验/NCT00079170
NCT00079170已完成不适用

A Pilot Study to Evaluate the Influence of Garlic on the Pharmacokinetics of Docetaxel in Patients With Metastatic Breast Cancer

National Cancer Institute (NCI)2 个研究点 分布在 1 个国家开始时间: 2004年1月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
试验地点
2

研究概览

简要总结

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether garlic supplements affect the ability of docetaxel to kill tumor cells.

PURPOSE: This clinical trial is studying how well giving docetaxel together with garlic works in treating patients with locally advanced or metastatic breast cancer.

详细描述

OBJECTIVES:

Primary

  • Determine the clinical pharmacokinetic behavior of docetaxel with and without garlic tablets in patients with locally advanced or metastatic breast cancer.
  • Determine the toxicity of this regimen in these patients.

Secondary

  • Determine the incidence of enzyme and transporter polymorphism in patients treated with this regimen.

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Nih

研究点 (2)

Loading locations...

相似试验

Docetaxel Plus Garlic in Treating Patients With... | 临床试验